TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hemorrhagic Fever
Research from Scripps Research Institute has provided new data on hemorrhagic fever
July 29th, 2008
New research, 'Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses,' is the subject of a report. According to a study from the United States, "Viral hemorrhagic fevers caused by the arenaviruses Lassa virus in Africa and Machupo, Guanarito, Junin, and Sabia virus in South America are among the most devastating emerging human diseases with fatality rates of 15-35% and a limited antiviral therapeutic repertoire available. Here we used high throughput screening of synthetic combinatorial small molecule libraries to identify inhibitors of arenavirus infection using pseudotyped virion particles bearing the glycoproteins (GPs) of highly pathogenic arenaviruses."...
Source: TB & Outbreaks Week (2008-07-29)
|
